News and Events

EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA—March 14, 2023—ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced it will publish full year 2022 financial and operating results on Tuesday, March 28, 2023. Management will also host a webcast to discuss operational and financial highlights, as well as provide a business update, on March 28, 2023, at 14:00 CEST / 08:00 EDT.

EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA – March 13, 2023 – ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced it does not hold cash deposits nor securities at Silicon Valley Bank (SVB).

EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA—February 23, 2023 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced it has been granted Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for the use of its ARC-EX platform for bladder control, alleviation of spasticity, and blood pressure regulation in people with SCI.

EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA—January 23, 2023 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced two key